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Abstract
Cyclodextrins (CDs) have long been used to manipulate cellular cholesterol levels both in vitro and in vivo, but their direct
effects at a cellular level are not well characterized. Recently, CDs have garnered much interest because of their ability to
clear stored cholesterol from Niemann Pick Type C (NPC) cells and markedly prolong the life of NPC1 disease mice. Here, we
investigate the hypothesis that treatment with 2-hydroxypropyl- b-cyclodextrin (HPB-CD) stimulates lysosomal exocytosis in
a calcium-enhanced manner. We propose that this exocytosis is the mechanism by which HPB-CD ameliorates the
endolysosomal cholesterol storage phenotype in NPC cells. These findings have significant implications for the use of HPB-
CD in biochemical assays and data interpretation as well as for their use for the treatment for NPC and other disorders.
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Introduction
Beta-cyclodextrins (CDs) are a family of cyclic oligosaccharides
composed of a hydrophilic outer surface and a hydrophobic core
that has a high affinity for sterols [1]. Because of these
characteristics, their use for the manipulation of cellular
cholesterol content has been pervasive [2], although the precise
mechanism of their actions has not been fully elucidated. They are
presumed to disrupt cholesterol-rich membrane domains and
sequester lipids within their core [3], but whether these actions are
limited to the plasma membrane or extend to organellar
membranes has not been established. A recent study showing
that CDs also extract sphingomyelin from lipid bilayers [4]
highlights the deficiency in our current knowledge regarding the
actions of CD in a cellular milieu.
Although CDs have been used as formulation vehicles by which
lipophilic drugs are incorporated into aqueous solutions, 2-
hydroxypropyl-b-cyclodextrin (HPB-CD) has itself been recently
approved for the treatment of Niemann Pick Type C (NPC)
disease [5], which is characterized by a massive accumulation of
lipids, including cholesterol, in the endosomal/lysosomal system.
HPB-CD has produced extremely promising results in a mouse
model of NPC1; it delays the onset of neurological symptoms and
can prolong their lifespan by up to ,120% [6,7,8]. Whether these
results will be directly translatable in human trials remains to be
determined. However, it is clear that questions regarding the mode
of its action, as well as the consequences of prolonged exposure to
the compound, are highly relevant for assessing the long-term
effects of HPB-CD as a potential therapeutic intervention.
In these studies, we examine the effects of HPB-CD on cells
derived from Wt and NPC1 mice. We show that exposure to HPB-
CD stimulates lysosomal exocytosis, which is enhanced in the
presence of extracellular calcium. During this process, endolyso-
somal components are extruded from cells, providing the basis for
observations that exposure to HPB-CD rapidly clears NPC cells of
stored cholesterol. To our knowledge, these findings represent the
first direct characterization of the mechanism of HPB-CD action
on cells, which have significant implications for both the use of
HPB-CD as a treatment vehicle and data interpretation in
experiments utilizing CD to manipulate cellular cholesterol levels.
Results
Exposure to cyclodextrin does not activate a stress-
induced signaling response
Cyclodextrins have long been used to extract plasma membrane
cholesterol, which can result in depletion of up to half of the total
cell cholesterol content within one hour of treatment [9]. Such a
rapid change in plasma membrane cholesterol could trigger stress-
induced signaling pathways, which could stimulate exosome
release as has been previously described [10]. One such pathway
is the stress-activated protein kinase/c-Jun N-terminal kinase
(SAPK/JNK) pathway [11]. Also, cyclodextrins may activate the
extracellular signal-regulated kinase (ERK) pathway; activated
phosphorylated ERK has a multitude of targets involved in cell
proliferation and survival. Cells derived from Wt BALB/c mice
that were treated with HPB-CD for up to 1 hour exhibited no
apparent increase in phosphorylated JNK (pJNK) or ERK (pERK)
levels (Fig. 1). Immediately following HPB-CD treatment, there
appears to be a slight increase in pERK (Fig. 1B, 0 min), but a
comparison with pERK pretreatment levels or pERK levels
immediately following treatment with vehicle alone did not reveal
any changes in pERK levels immediately following treatment
(Fig. 1C). The fact that the decreased levels of pERK between 0
and 15 minutes occur in both untreated and treated cells suggests
that this particular response is not due to HPB-CD exposure but
instead to the treatment conditions. Furthermore, the levels of the
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these pathways are not affected by exposure to HPB-CD. These
results indicate that the ability of HPB-CD to ameliorate the
cholesterol storage phenotype in NPC mice is not due to activation
of stress-induced signaling pathways.
Exposure to cyclodextrin alters the cholesterol storage
phenotype of NPC1 cells
One of the biochemical hallmarks of NPC disease is the
accumulation of free cholesterol in vesicles of the endosomal/
lysosomal system, which can be visualized in cultured cells with the
fluorescent antibiotic filipin. Since HPB-CD treatment reduces
free cholesterol levels in various organs of NPC1 mice [6,7], we
first determined if the compound has a similar effect in cell lines
derived from these NPC1 BALB/c mice. As expected, untreated
cells (Fig 2, 0%) exhibit bright, punctate filipin staining that is
indicative of accumulated free cholesterol in endocytic vesicles.
The filipin intensity decreases as the HPB-CD concentration
increases, indicating that exposure to the compound reduces the
amount of stored cholesterol in these cells. Interestingly, at the
highest concentration tested, the effectiveness of HPB-CD in
clearing stored cholesterol appears somewhat decreased (Fig. 2,
0.4%). This result might be due to slight toxicity effects from
overnight incubation with the compound, which has previously
been reported in cultured cells [12].
Because the effects of HPB-CD on cholesterol metabolism have
been shown to occur very rapidly in cultured cells [12], we next
determined the toxicity threshold for acute HPB-CD treatment in
cell lines derived from Wt and NPC1 BALB/c mice. Cells treated
with increasing concentrations of HPB-CD for 2 hours were
assessed for cell viability using an MTT assay [13]. Neither cell
lineshowssensitivitytoHPB-CDatconcentrationsupto6%(Fig.3).
TheNPC1 cells(Fig.3,circles)beginto exhibitdecreasedsurvival at
8% HPB-CD (P,0.01), whereas Wt cells (Fig. 3, squares) are
completely resistant up to 10% HPB-CD (P,0.05), suggesting that
NPC1 cells are more sensitive to the compound than Wt cells at
higher concentrations. All subsequent acute studies were performed
using 2% HPB-CD to ensure the lowest cellular toxicity.
Figure 1. The effect of HPB-CD on stress-related protein kinases. Representative western blot analyses of total (pan) and phosphorylated (p)
ERK (A) and JNK (B and C) in lysates from Wt cells treated with HPB-CD. The blots shown are representative of 3 independent experiments.
doi:10.1371/journal.pone.0015054.g001
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cellular level, NPC1 cells were treated with 2% HPB-CD for up to
90 minutes and stained with filipin. As expected, untreated NPC1
cells contain a profusion of vesicles that are filled with free
cholesterol (Fig. 4, 0 min). Interestingly, at subsequent time points,
larger bright vesicles begin to appear (Fig. 4, 15–60 min, arrow).
Cells that contain these larger vesicles do not stain as brightly as
their surrounding cells, suggesting that cholesterol may be
concentrating in these larger vesicular structures within the cell.
The number and size of these larger vesicles increases with time,
but by 90 minutes, the number of these structures has decreased
(Fig. 4, graph). Taken together, these results suggest that HPB-CD
causes cholesterol to concentrate in large vesicular structures,
which is consistent with the early stages of lysosomal exocytosis, in
which larger vesicles form via vesicle fusion before they are
extruded from the cell [14].
Exposure to HPB-CD induces the secretion of endosomal/
lysosomal proteins from cells in a calcium-enhanced
manner
A single dose of HPB-CD has been shown to dramatically
reduce the unesterified cholesterol pool in NPC1 mice as early as
24 hours after administration, with a concomitant increase in
cholesteryl ester formation and fecal bile acid excretion [8,15].
The speed of this response led us to hypothesize that cholesterol
exits cells en masse via lysosomal exocytosis. In cultured cells,
administration of the calcium ionophore ionomycin has been
shown to stimulate lysosomal exocytosis within minutes by
elevating intracellular calcium levels [16,17].
To determine if cyclodextrin, similarly to ionomycin, induces
lysosomal exocytosis, the culture media of Wt and NPC1 cells were
analyzed for the presence of the lysosomal enzyme b-hexosamin-
idase (b-hex) as a marker for lysosomal content secretion. In both
cell types, there is a significant increase in b-hex activity in the
culture media of treated cells compared to untreated cells after 30
minutes (Fig. 5A, closed circles and squares). Furthermore, the
level of enzyme activity in the media of treated NPC cells is slightly
higher than that found in Wt cells after 60 minutes (Fig. 5A, closed
squares), which suggests that NPC cells may be slightly more
sensitive to HPB-CD than Wt cells. The appearance of b-hex in
the culture media of HPB-CD-treated cells is not a result of
generalized cell lysis, since the levels of lactate dehydrogenase in
the media remained unchanged in both cells types for the duration
of the assay (data not shown).
To evaluate the effect of calcium on HPB-CD-induced b-hex
secretion, Wt cells were treated with HPB-CD in the presence and
absence of calcium. In untreated cells in the presence and absence
of calcium, there is a small percentage of enzyme in the media,
which did not increase significantly over time (Fig. 5B, None,
P.0.1). In contrast, the media from cells treated with HPB-CD in
the presence of calcium contain increasing levels of b-hex over
time (Fig. 5B, CD/Ca
2+), and furthermore, these levels are higher
than the levels found in the media of cells treated in the absence of
calcium (Fig. 5B, CD). These studies were performed in the
presence of mannose 6-phosphate to prevent reuptake of b-hex via
the plasma membrane mannose 6-phosphate receptor. These
results indicate that the induction of b-hex secretion from HPB-
CD-treated cells is enhanced by the presence of extracellular
calcium. Comparable results were obtained with ionomycin,
which affects the release of intracellular calcium stores and the
influx of extracellular calcium [18]. Similar to published reports
[17], in the absence of calcium, ionomycin has little effect on b-hex
secretion (Fig. 5C, Iono), whereas in the presence of calcium, there
is a 2-fold increase in enzyme found in the culture media (Fig. 5C,
Iono/Ca
2+).
Treatment with HPB-CD also stimulated the secretion of
flotillin 2, a protein associated with lipid rafts and endolysosomes
[19] and a marker for exosomes [20]. These endolysosomal-
derived vesicles are released in a calcium dependent manner into
the extracellular milieu upon fusion of multivesicular bodies with
the plasma membrane [14,21]. Exosomes are normally secreted by
most cells and have a number of functions, including a role in
intercellular communication [22]. In untreated cells, low levels of
flotillin can be detected in both the presence and absence of
calcium (Fig. 6, -), although there is slightly more protein in the
calcium-positive sample. Treatment with HPB-CD in the absence
of calcium has no effect on exosome secretion compared to
Figure 2. Filipin staining of free cholesterol in NPC1 cells treated with HPB-CD for 20 hours. Filipin intensity was quantitated in at least
150 cells for each sample. The bar graph represents average values from 3 independent experiments. *P,0.0001.
doi:10.1371/journal.pone.0015054.g002
Figure 3. HPB-CD toxicity in cell lines derived from BALB/c
mice. Wt (squares) and NPC1 (circles) cells were treated with increasing
concentrations of HPB-CD for 2 hours and their percent survival was
determined using the MTT assay as described in ‘‘Materials and
Methods’’. * and ** denote statistically significant differences between
treated and untreated cells with P,0.01 and P,0.05, respectively.
doi:10.1371/journal.pone.0015054.g003
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levels of flotillin increase (Fig. 6 CD+), indicating an increase in
exosome release. This effect of HPB-CD on exosome secretion is
similar to, albeit not as potent as, that of ionomycin (Fig. 6, Iono+),
which is well known to greatly stimulate exosome secretion [23].
Taken together, these results indicate that HPB-CD treatment
induces a rapid, calcium-dependent endolysosomal secretion.
Endosomal proteins relocalize to the plasma membrane
following HPD-CD treatment
To determine if the NPC1 compartment participates in exocytosis
following HPD-CD treatment, a GFP-tagged NPC1 protein was
transiently expressed in Wt cells. As expected, transfected cells show
the tagged protein being targeted to endolysosomal vesicles scattered
throughout the cell (Fig. 7A). However, after exposure to HPB-CD, a
majority of the transfected cells (.60%) contain NPC-positive vesicles
that have relocalized near the plasma membrane, presumably prior to
fusion with the membrane (Fig. 7B and inset).In support of this notion,
similar relocalization of NPC1-containing vesicles is observed after
treatment with ionomycin (Fig. 7C and inset), a compound known to
induce this type of vesicle relocation as discussed above [17]. These
studies provide compelling evidence that endolysosomal constituents
are targeted for cellular exocytosis after HPB-CD treatment.
Discussion
Very little has previously been known regarding the mecha-
nisms of HPB-CD action. The ability of HPB-CD to improve
disease progression in NPC1 mice [6,15] has prompted its recent
approval for treatment of NPC1 patients [5]. Although CDs have
not generally been considered toxic [24], one recent study showed
that several CDs promote the toxic aggregation of beta-amyloid in
vitro [25]. Such observations make the careful elucidation of CD’s
actions critical for accurate assessment of long-term outcomes.
Because HPB-CD can bind and extract cholesterol from
membranes, it has generally been assumed that this is the
mechanism by which HPB-CD clears cholesterol from NPC1
cells. However, there are several questions to arise from this
scenario. First, the accumulated cholesterol in NPC1 cells is
located in endolysosomal vesicles, and it has never been
established that the hydrophilic HPB-CD can cross the plasma
membrane and/or organellar membranes. One recent study
suggests that cyclodextrins are endocytosed; however, the
cyclodextrins in that study were coupled to dextran [26], which
is known to enter the endolysosomal system via endocytosis [27].
Furthermore, assuming that HPB-CD can be endocytosed and
reach the appropriate compartment to complex with cholesterol, it
is also not clear how these HPB-CD-cholesterol complexes can
then exit these compartments and redistribute cholesterol to other
cellular pools. Finally, several studies indicate that HPB-CD is
unable to cross the blood-brain barrier [6,28,29], so the
mechanism by which HPB-CD improves the neurological
symptoms in NPC1 mice [27] remains a great open question.
If CDs extract lipids from cellular membranes as is currently
accepted [1,3], one possible consequence would be the permea-
bilization of those membranes to small ions such as calcium.
Indeed, CDs have been shown to create ‘‘holes’’ in human and
simian immunodeficiency virus membranes as well as in artificial
lipid bilayers [4,30]. Microdisruptions in the plasma membrane
are normally repaired in cells by lysosomal exocytosis, during
which endolysosomes fuse with the plasma membrane [31]. The
resealing process is calcium-dependent and results in the extrusion
of lysosomal contents from the cell [31]. Because the large
structures that are observed after acute exposure to HPB-CD
(Figure 4) are not visible prior to HPB-CD treatment, we
hypothesize that they are formed through fusion of smaller vesicles
prior to extrusion from the cell. However, it is possible that they
may be formed via alternate mechanisms or that they may be pre-
existing structures into which cholesterol is shuttled after HPB-CD
treatment and thus appear positive by filipin staining. The release
of b-hex and flotillin, but not lactate dehydrogenase, into the
media of HPB-CD-treated cells is consistent with the specific
release of endolysosomal contents in a calcium-enhanced manner.
Furthermore, a recent study showing that cholesterol can exit cells
via exosomes [32] supports our hypothesis that the mechanism by
which HPB-CD induces the ‘‘emptying’’ of cholesterol and
presumably other lipids from NPC1 cells is lysosomal exocytosis.
The cellular events by which this process is induced remain
unclear. Our studies suggest that stress-related signaling pathways
are not involved (Figure 1). As discussed above, damage to the
Figure 4. Enlarged cholesterol-filled vesicles in NPC1 cells treated with HPB-CD. Cholesterol-filled vesicles fuse to form larger vesicles
(arrows), the number of which increases with time. The bar graph represents the percentage of cells with at least one enlarged vesicle (with a
minimum size of 10 microns) out of 150 cells and is representative of 2 independent experiments.
doi:10.1371/journal.pone.0015054.g004
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is also possible that HPB-CD activates other signaling pathways, as
has recently been described for cell migration during leukocyte
chemotaxis [33]. The observation that lysosomal exocytosis plays
such an important role in chemotaxis is relevant to these studies,
since it indicates that exocytosis can occur for prolonged periods of
time and not only in response to acute injury of the plasma
membrane. The lipid accumulation in NPC disease is so massive
that short exposure times to HPB-CD produce no discernible
decreases in free cholesterol levels (data not shown), even as
lysosomal enzymes are being secreted into the media. However,
longer exposure times (.20 hours) produce a significant decrease
in free cholesterol levels (Figure 2), suggesting that a prolonged
dose of HPB-CD is necessary to effect clearance of stored
intracellular lipids.
These findings should provide insight into the mechanism of
CD action in the treatment of disease. For disorders such as NPC,
in which there is accumulation in the endolysosomal system, it
may not be necessary to receive continuous doses of HPB-CD
since the accumulation of lipids occurs over time. With respect to
the therapeutic effects of CD on NPC disease, many questions
remain, such as what happens to the lipids following lysosomal
exocytosis? Does CD cause relocalization of lipids to the plasma
membrane via exocytosis and reabsorption, or do neighboring
cells take up and process/digest these regurgitated lipids? Further
studies are necessary to determine the exact in vivo mechanism of
CD action. Finally, caution should be exercised in the interpre-
tation of experimental data involving the use of CD to extract or
manipulate plasma membrane cholesterol since these studies
indicate that CDs have pleiotropic effects on cellular physiology.
Materials and Methods
Materials
Pharmaceutical grade 2-Hydroxypropyl- b-cyclodextrin (HPB-
CD; trade name Trappsol) was a kind gift of CTD, Inc. Chemicals
were from Sigma-Aldrich (Milwaukee, WI) unless otherwise
indicated. Filipin was from Polysciences Inc., (Warrington, PA).
OPTIMEM and Lysosensor Green-189 were from Invitrogen
(Carlsbad, CA). FuGENE
TM 6 transfection reagent was from
Roche Diagnostics. The ERK and JNK antibodies were from Cell
Signaling Technology (Beverly, MA). The GAPDH antibody was
from Millipore (Billerica, MA) and the flotillin 2 antibody was
from BD Biosciences (San Jose, CA).
Cell lines, transfection, and microscopy
We have previously described the establishment and mainte-
nance of Wt and NPC1 cell lines derived from BALB/c mice [34].
Cells were treated with 2% HPB-CD in OPTIMEM in
experiments except where otherwise indicated.
For filipin staining, cells were incubated with HPB-CD and then
stained with filipin as we have previously described [35].
Fluorescence was analyzed using a Nikon Eclipse microscope
fitted with a charge-coupled-device camera. Images were acquired
with MetaVue software using the same exposure time for all
samples and then deconvoluted using AutoDeblur software.
Fluorescence intensity was determined using the integrated
Figure 5. Secretion of the lysosomal enzyme b-hexosaminidase
by HPB-CD-treated cells. (A) Wt (circles) and NPC1 (squares) cells
were incubated with (closed shapes) or without (open shapes) 2% HPB-
CD. At the indicated times, an aliquot of media was assayed for b-
hexosaminidase activity. (B) Wt cells were incubated with 2% HPB-CD in
the presence (closed shapes) or absence (open shapes) of calcium and
an aliquot of media was assayed for b-hexosaminidase activity. (C) Wt
cells were incubated with 1 mM ionomycin for 20 min in the presence
(closed shapes) or absence (open shapes) of calcium and an aliquot of
media was assayed for b-hexosaminidase activity. All enzyme activities
are expressed as the percentage of the total enzyme activity found in
media and cells. * and ** denote statistically significant differences
between treated and untreated cells with P,0.01 and P,0.05,
respectively.
doi:10.1371/journal.pone.0015054.g005
Figure 6. Secretion of exosomes in HPB-CD-treated cells. Wt
cells incubated with PBS (2), 2% HPB-CD (CD), or 1 mM ionomycin
(Iono) show differential secretion of exosomes in the presence (+)o r
absence (2) of calcium, as determined by the presence of flotillin in the
culture media. Equal loading was determined by normalizing to GAPDH
levels in the cell lysate.
doi:10.1371/journal.pone.0015054.g006
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quantitated for each sample and each experiment was repeated 3
times.
Transient overexpression of the NPC1 protein fused to GFP
(pGS-NPC1-GFP) was carried out by transfecting cells at 60%
confluency using FuGENE 6 reagent according to the manufac-
turer’s recommendations. At 24 h post-transfection, cells were
treated with HPB-CD for 15 min or 1 mM ionomycin for 30 min
before live cells were mounted onto glass slides and analyzed for
NPC1-GFP expression.
Western blot analyses
For ERK/JNK westerns, cells were incubated with HPB-CD
for the indicated times and then lysed in buffer (150 mM NaCl,
50 mM Na2HPO4, pH 6.9, 1 mM EDTA, 1% Igepal) for 5 min
at 4uC. Lysates were clarified by centrifugation at 20,000 g for
5 min and protein concentrations were determined using the
fluorescamine method as we have described [36]. Between 15–
30 mg of protein was subjected to electrophoresis through a 4–
12% Bis-Tris pre-cast gel (Invitrogen, Carlsbad, CA, U.S.A.) in
MES buffer and transferred on to a Protran membrane as we have
described [34]. Proteins were visualized by chemiluminescence
using SuperSignal West Dura substrate (Thermo Scientific,
Rockford, IL) on a FluorChemQ imager using AlphaView
software (Alpha Innotech, San Leandro, CA).
For exosome isolation, cells were incubated with HPB-CD or
1 mM ionomycin in PBS for 30 minutes at 37uC. The media was
collected and exosomes isolated by centrifugation at 100,000 g for
1 hr. Exosomes were resuspended in 20 mM Tris-HCl, pH 8.0
and sonicated 365 minutes in a bath sonicator. Cells were lysed
and cellular protein concentrations determined as described
above. Exosome loading was normalized to the cell lysate protein
concentrations.
MTT Assays
Cells were seeded at 15,000 cells/well in a 96-well plate and
incubated overnight at 37uC. The next day they were incubated
with HPB-CD for 2 hr at 37uC, and cell viability was assessed by
an MTT assay as described [37].
b-hexosaminidase assays
Cells were incubated with HPB-CD or 1 mM ionomycin and
2 mM mannose-6-phosphate at 37uC. For calcium studies, cells
were incubated with the appropriate compounds in PBS and
1.2 mM CaCl2 was supplemented for the calcium-positive
samples. At the indicated time points, an aliquot of media was
removed and assayed for b-hex activity at 37uC and pH 4.4 by
using the synthetic substrate 4-methylumbelliferyl-N-acetyl-gluco-
saminide as has been previously described [34]. After the last time
point, cells were lysed as described above and an aliquot of the
lysate assayed for b-hex activity to determine the total enzyme
activity of each sample. Enzyme activities are expressed as a
percentage of the total enzyme activity found in the media and
lysate.
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